Canopy Growth Corp. (NASDAQ:CGC) is a major player in the cannabis industry. The company faces intense competition from rivals like Tilray Brands (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON). Investors are watching for its upcoming financial results, which are scheduled for release on June 15, 2026, before the market opens.
For the upcoming quarter, Wall Street expects Canopy Growth to report an earnings per share (EPS) of -$0.06. An EPS shows how much profit a company makes for each share of its stock. The consensus revenue estimate for the quarter is approximately $53.43 million.
These estimates come as Canopy Growth consistently struggles to achieve profitability. The company has a negative price-to-earnings (P/E) ratio of -1.53. A negative P/E ratio indicates that the company has experienced net losses over the past year, which has concerned many investors.
Adding to investor concerns, Canopy Growth announced it will restate two years of financial results due to an accounting error. As highlighted by The Motley Fool, the stock has also dropped by more than 12% since the start of May, showing a negative investor sentiment.
Despite these challenges, the company shows some financial stability. Its current ratio is 5.34, suggesting a strong ability to cover short-term bills. Furthermore, Canopy Growth maintains a debt-to-equity ratio of 0.34, which measures its financial leverage by comparing debt to shareholder funds.
